Novasep (Lyon, France) and Sartorius (Göttingen, Germany) have announced the completion of the sale of Novasep’s chromatography equipment division to Sartorius.
Novasep’s chromatography equipment division comprises resin‑based batch and intensified chromatography systems and focuses on low and high pressure for small and large molecules such as monoclonal antibodies, oligonucleotides, peptides, and insulin. The division generated sales of around 40 million euros in 2020, with the majority of the approximately 100 employees working at Novasep’s Pompey site in eastern France and some in the USA, China, and India.
Since 2018, Novasep and Sartorius have been collaborating in the joint development of an optimized membrane-based, low‑pressure chromatography system that processes larger molecules more productively.
“This achievement strengthens our relationship with the Sartorius team and represents a great opportunity for the chromatography equipment business to fully deliver its potential and accelerate its growth under this new ownership,” said Michel Spagnol, President and CEO of Novasep.
Novasep will continue to offer CDMO development and manufacturing services for the pharmaceutical and biopharmaceutical markets, based on chromatography, which remains a core technology.
For more information, please visit: www.novasep.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.